Header Logo

Connection

Michael Liptay to Humans

Back to Details
This is a "connection" page, showing publications Michael Liptay has written about Humans.
Michael Liptay
Connection Strength
0.962
Humans
  1. Commentary: Low tidal volume ventilation: How low can you go? J Thorac Cardiovasc Surg. 2022 04; 163(4):1586-1587.
    View in: PubMed
    Score: 0.042
  2. Improved False-Positive Rates and the Overestimation of Unintended Harm from Lung Cancer Screening. Lung. 2019 06; 197(3):327-332.
    View in: PubMed
    Score: 0.037
  3. 50th Anniversary Landmark Commentary on Jensik RJ, Faber LP, Kittle CF. Segmental resection for bronchogenic carcinoma. Ann Thorac Surg 1979;28:475-83. Ann Thorac Surg. 2015 Sep; 100(3):776-7.
    View in: PubMed
    Score: 0.029
  4. Smaller incisions for smaller cancers. Oncology (Williston Park). 2015 Mar; 29(3):166; 168.
    View in: PubMed
    Score: 0.028
  5. Status of sentinel lymph node mapping in non-small cell lung cancer. Cancer J. 2015 Jan-Feb; 21(1):17-20.
    View in: PubMed
    Score: 0.028
  6. Multimodality treatment of pleural mesothelioma. Surg Oncol Clin N Am. 2013 Apr; 22(2):345-55.
    View in: PubMed
    Score: 0.024
  7. Anterior mediastinal mass secondary to histoplasmosis. Ann Thorac Surg. 2012 Jan; 93(1):e9-10.
    View in: PubMed
    Score: 0.023
  8. Adenocarcinoma in a 40-year-old colonic interposition treated with Ivor Lewis esophagectomy and esophagogastric anastomosis. Ann Thorac Surg. 2011 Dec; 92(6):e113-4.
    View in: PubMed
    Score: 0.022
  9. The early years: how to set up and build your practice. Thorac Surg Clin. 2011 Aug; 21(3):341-7.
    View in: PubMed
    Score: 0.022
  10. Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer. Lung Cancer. 2011 Feb; 71(2):186-90.
    View in: PubMed
    Score: 0.020
  11. Diffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer. J Surg Oncol. 2009 Dec 15; 100(8):703-7.
    View in: PubMed
    Score: 0.020
  12. An unusual case of Aspergillus fibrosing mediastinitis. Ann Thorac Surg. 2009 Oct; 88(4):1352-4.
    View in: PubMed
    Score: 0.019
  13. Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does "side" really matter? Ann Thorac Surg. 2009 Sep; 88(3):937-43; discussion 944.
    View in: PubMed
    Score: 0.019
  14. Bilobectomy for non-small cell lung cancer: a search for clinical factors that may affect perioperative morbidity and long-term survival. J Thorac Cardiovasc Surg. 2010 Mar; 139(3):606-11.
    View in: PubMed
    Score: 0.019
  15. Enucleation of a giant esophageal gastrointestinal stromal tumor. Ann Thorac Surg. 2009 May; 87(5):1603-5.
    View in: PubMed
    Score: 0.019
  16. Establishment of a multi-analyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer. J Thorac Oncol. 2009 Mar; 4(3):338-47.
    View in: PubMed
    Score: 0.019
  17. Intraoperative sentinel node mapping with technitium-99 in lung cancer: results of CALGB 140203 multicenter phase II trial. J Thorac Oncol. 2009 Feb; 4(2):198-202.
    View in: PubMed
    Score: 0.018
  18. Sentinel node mapping in lung cancer: introduction. Semin Thorac Cardiovasc Surg. 2009; 21(4):297.
    View in: PubMed
    Score: 0.018
  19. Cytologic imprints of giant atypical bronchopulmonary carcinoid tumor of the lung with extensive oncocytic component. Diagn Cytopathol. 2008 Dec; 36(12):887-90.
    View in: PubMed
    Score: 0.018
  20. Repeat pulmonary resection for metachronous colorectal carcinoma is beneficial. Surgery. 2008 Oct; 144(4):712-7; discussion 717-8.
    View in: PubMed
    Score: 0.018
  21. Invited commentary. Ann Thorac Surg. 2008 Aug; 86(2):395.
    View in: PubMed
    Score: 0.018
  22. Sentinel node mapping in lung cancer: the Holy Grail? Ann Thorac Surg. 2008 Feb; 85(2):S778-9.
    View in: PubMed
    Score: 0.017
  23. Identification of clinical factors predicting Pleurx catheter removal in patients treated for malignant pleural effusion. Eur J Cardiothorac Surg. 2008 Jan; 33(1):89-94.
    View in: PubMed
    Score: 0.017
  24. Metastatic breast cancer and lung cancer within the same lymph node. Int J Surg Pathol. 2007 Apr; 15(2):169.
    View in: PubMed
    Score: 0.016
  25. In vivo sentinel lymph node mapping in lung cancer. Ann Surg Oncol. 2005 Feb; 12(2):102-3.
    View in: PubMed
    Score: 0.014
  26. Sentinel lymph node mapping in lung cancer. Cancer Treat Res. 2005; 127:141-50.
    View in: PubMed
    Score: 0.014
  27. Sentinel node mapping in lung cancer. Ann Surg Oncol. 2004 Mar; 11(3 Suppl):271S-4S.
    View in: PubMed
    Score: 0.013
  28. Intermittent airway obstruction and superior vena cava syndrome in a patient with an undiagnosed mediastinal mass after cesarean delivery. Anesth Analg. 2003 Sep; 97(3):883-884.
    View in: PubMed
    Score: 0.013
  29. Predicting Non-home Discharge After Lung Surgery: Analysis of the General Thoracic Surgery Database. Ann Thorac Surg. 2023 03; 115(3):687-692.
    View in: PubMed
    Score: 0.012
  30. The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer. Oncotarget. 2022; 13:393-407.
    View in: PubMed
    Score: 0.011
  31. Definition and assessment of high risk in patients considered for lobectomy for stage I non-small cell lung cancer: The American Association for Thoracic Surgery expert panel consensus document. J Thorac Cardiovasc Surg. 2021 12; 162(6):1605-1618.e6.
    View in: PubMed
    Score: 0.011
  32. Redefining the Risk of Surgery for Clinical Stage IIIA (N2) Non-Small Cell Lung Cancer: A Pooled Analysis of the STS GTSD and ESTS Registry. Lung. 2021 06; 199(3):311-318.
    View in: PubMed
    Score: 0.011
  33. Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer. Ann Thorac Surg. 2000 Aug; 70(2):384-9; discussion 389-90.
    View in: PubMed
    Score: 0.010
  34. Solitary pulmonary nodule: treatment options. Chest. 1999 Dec; 116(6 Suppl):517S-518S.
    View in: PubMed
    Score: 0.010
  35. A Prolonged Air Leak Score for Lung Cancer Resection: An Analysis of The Society of Thoracic Surgeons General Thoracic Surgery Database. Ann Thorac Surg. 2019 11; 108(5):1478-1483.
    View in: PubMed
    Score: 0.010
  36. Malignant bone tumors of the chest wall. Semin Thorac Cardiovasc Surg. 1999 Jul; 11(3):278-84.
    View in: PubMed
    Score: 0.009
  37. Complications from induction regimens for thoracic malignancies. Perioperative considerations. Chest Surg Clin N Am. 1999 Feb; 9(1):79-95.
    View in: PubMed
    Score: 0.009
  38. Circulating histocompatibility antigen (HLA) gene products may help differentiate benign from malignant indeterminate pulmonary lesions. Hum Immunol. 2018 Jul; 79(7):558-563.
    View in: PubMed
    Score: 0.009
  39. Development of bead based multiplexed immunoassay for evaluation of midkine, syndecan-1, and ANGPTL4 in patient serum. J Immunoassay Immunochem. 2018; 39(1):84-98.
    View in: PubMed
    Score: 0.009
  40. Reply. Ann Thorac Surg. 2018 07; 106(1):316-317.
    View in: PubMed
    Score: 0.009
  41. Serum Biomarkers May Prognosticate Recurrence in Node-Negative, Non-Small Cell Lung Cancers Less Than 4 Centimeters. Ann Thorac Surg. 2017 Nov; 104(5):1637-1643.
    View in: PubMed
    Score: 0.008
  42. Durability of Silicone Airway Stents in the Management of Benign Central Airway Obstruction. Lung. 2017 10; 195(5):601-606.
    View in: PubMed
    Score: 0.008
  43. The History of the Department of Cardiovascular and Thoracic Surgery at Rush. Semin Thorac Cardiovasc Surg. 2016 Autumn; 28(3):687-699.
    View in: PubMed
    Score: 0.008
  44. Number of Ribs Resected is Associated with Respiratory Complications Following Lobectomy with en bloc Chest Wall Resection. Lung. 2016 08; 194(4):619-24.
    View in: PubMed
    Score: 0.008
  45. Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer. J Thorac Cardiovasc Surg. 2016 Jul; 152(1):55-61.e1.
    View in: PubMed
    Score: 0.008
  46. Survival Benefit of Surgery after Chemoradiotherapy for Stage III (N0-2) Non-Small-Cell Lung Cancer Is Dependent on Pathologic Nodal Response. J Thorac Oncol. 2015 Oct; 10(10):1475-80.
    View in: PubMed
    Score: 0.007
  47. Angiogenesis Biomarkers May Be Useful in the Management of Patients With Indeterminate Pulmonary Nodules. Ann Thorac Surg. 2015 Aug; 100(2):429-36.
    View in: PubMed
    Score: 0.007
  48. Thoracoscopic staging and surgical therapy for esophageal cancer. Chest. 1995 Jun; 107(6 Suppl):218S-223S.
    View in: PubMed
    Score: 0.007
  49. Mesothelioma and radical multimodality therapy: who benefits? Chest. 1995 Jun; 107(6 Suppl):345S-350S.
    View in: PubMed
    Score: 0.007
  50. Relationship Between Radiation Therapy Dose and Outcome in Patients Treated With Neoadjuvant Chemoradiation Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer: A Population-Based, Comparative Effectiveness Analysis. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):307-16.
    View in: PubMed
    Score: 0.007
  51. Comparative effectiveness of neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery for patients with stage IIIA non-small cell lung cancer. Lung Cancer. 2015 Jun; 88(3):267-74.
    View in: PubMed
    Score: 0.007
  52. Early pneumonectomy for pulmonary mucormycosis. Ann Thorac Surg. 2015 Mar; 99(3):e67-8.
    View in: PubMed
    Score: 0.007
  53. Circulating angiogenesis biomarkers are associated with disease progression in lung adenocarcinoma. Ann Thorac Surg. 2014 Dec; 98(6):1968-75; discussion 1975.
    View in: PubMed
    Score: 0.007
  54. Value of circulating insulin-like growth factor-associated proteins for the detection of stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2015 Mar; 149(3):727-34.e1-3; discussion 734.
    View in: PubMed
    Score: 0.007
  55. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base. Cancer. 2014 Jul 01; 120(13):2060-8.
    View in: PubMed
    Score: 0.007
  56. Prevalence and predictors of neoadjuvant therapy for stage IIIA non-small cell lung cancer in the National Cancer Database: importance of socioeconomic status and treating institution. Int J Radiat Oncol Biol Phys. 2014 Jun 01; 89(2):303-12.
    View in: PubMed
    Score: 0.007
  57. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules. J Thorac Oncol. 2013 Jan; 8(1):31-6.
    View in: PubMed
    Score: 0.006
  58. Prognostic significance of weight gain during definitive chemoradiotherapy for locally advanced non-small-cell lung cancer. Clin Lung Cancer. 2013 Jul; 14(4):370-5.
    View in: PubMed
    Score: 0.006
  59. CDKN2A (p16) promoter hypermethylation influences the outcome in young lung cancer patients. Diagn Mol Pathol. 2012 Dec; 21(4):207-13.
    View in: PubMed
    Score: 0.006
  60. Development of a serum biomarker panel predicting recurrence in stage I non-small cell lung cancer patients. J Thorac Cardiovasc Surg. 2012 Dec; 144(6):1344-50; discussion 1350-1.
    View in: PubMed
    Score: 0.006
  61. Esophageal carcinoma advances in treatment results for locally advanced disease: review. Ann Oncol. 2012 May; 23(5):1095-1103.
    View in: PubMed
    Score: 0.006
  62. Biomarkers of the insulin-like growth factor pathway predict progression and outcome in lung cancer. Ann Thorac Surg. 2011 Nov; 92(5):1805-11; discussion 1811.
    View in: PubMed
    Score: 0.006
  63. Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients. J Thorac Oncol. 2011 Jun; 6(6):1079-86.
    View in: PubMed
    Score: 0.005
  64. Neoadjuvant chemoradiation for clinically advanced non-small cell lung cancer: an analysis of 233 patients. Ann Thorac Surg. 2011 Jul; 92(1):233-41; discussion 241-3.
    View in: PubMed
    Score: 0.005
  65. Enhancement of a multianalyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer with circulating autoantibody biomarkers. Int J Cancer. 2011 Jul 01; 129(1):133-42.
    View in: PubMed
    Score: 0.005
  66. Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survival. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):985-91.
    View in: PubMed
    Score: 0.005
  67. A multi-analyte serum test for the detection of non-small cell lung cancer. Br J Cancer. 2010 Oct 12; 103(8):1221-8.
    View in: PubMed
    Score: 0.005
  68. STS database risk models: predictors of mortality and major morbidity for lung cancer resection. Ann Thorac Surg. 2010 Sep; 90(3):875-81; discussion 881-3.
    View in: PubMed
    Score: 0.005
  69. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer. Clin Cancer Res. 2010 Jul 01; 16(13):3452-62.
    View in: PubMed
    Score: 0.005
  70. PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients. Int J Cancer. 2010 Apr 01; 126(7):1630-9.
    View in: PubMed
    Score: 0.005
  71. Age is a strong risk factor for atrial fibrillation after pulmonary lobectomy. Am J Surg. 2010 Apr; 199(4):558-61.
    View in: PubMed
    Score: 0.005
  72. Cytologic features of adult spindle cell variant of rhabdomyosarcoma: a report of two cases. Diagn Cytopathol. 2009 Dec; 37(12):932-4.
    View in: PubMed
    Score: 0.005
  73. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy. Ann Thorac Surg. 2009 Sep; 88(3):945-50; discussion 950-1.
    View in: PubMed
    Score: 0.005
  74. A 74-year-old man with an enlarging pleural-based mass that was not a mesothelioma. Thorac Cardiovasc Surg. 2009 Jun; 57(4):244-6.
    View in: PubMed
    Score: 0.005
  75. Endobronchial colorectal metastasis versus primary lung cancer: a tale of two sleeve right upper lobectomies. Interact Cardiovasc Thorac Surg. 2009 Aug; 9(2):379-81.
    View in: PubMed
    Score: 0.005
  76. Simultaneous costal cartilage-sparing modified Ravitch procedure and latissimus dorsi transfer for chest wall deformity repair in Poland's syndrome. J Pediatr Surg. 2009 Jan; 44(1):e29-32.
    View in: PubMed
    Score: 0.005
  77. Utility of silicone esophageal bypass stents in the management of delayed complex esophageal disruptions. Ann Thorac Surg. 2008 Jun; 85(6):1962-7; discussion 1967.
    View in: PubMed
    Score: 0.004
  78. Contemporary review on the inequities in the management of lung cancer among the African-American population. J Natl Med Assoc. 2008 Jun; 100(6):683-8.
    View in: PubMed
    Score: 0.004
  79. A case of mediastinitis following botulinum toxin type A treatment for achalasia. Nat Clin Pract Gastroenterol Hepatol. 2007 Oct; 4(10):579-82.
    View in: PubMed
    Score: 0.004
  80. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer. Lung Cancer. 2004 Aug; 45(2):243-53.
    View in: PubMed
    Score: 0.003
  81. Critical factors for patient management. Lung Cancer. 2003 Dec; 42 Suppl 1:S7-8.
    View in: PubMed
    Score: 0.003
  82. Continuous paravertebral extrapleural infusion for post-thoracotomy pain management. Surgery. 1999 Oct; 126(4):650-6; discussion 656-7.
    View in: PubMed
    Score: 0.002
  83. Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer. J Thorac Cardiovasc Surg. 1997 Apr; 113(4):691-8; discussion 698-700.
    View in: PubMed
    Score: 0.002
  84. Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg. 1997 Feb; 63(2):334-8.
    View in: PubMed
    Score: 0.002
  85. Small pulmonary lesions detected at CT: clinical importance. Radiology. 1997 Jan; 202(1):105-10.
    View in: PubMed
    Score: 0.002
  86. Video-assisted thoracic surgery in the elderly. A review of 307 cases. Chest. 1996 Sep; 110(3):751-8.
    View in: PubMed
    Score: 0.002
  87. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. Ann Surg. 1996 Sep; 224(3):288-94; discussion 294-6.
    View in: PubMed
    Score: 0.002
  88. Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias. Ann Thorac Surg. 1996 Mar; 61(3):977-82.
    View in: PubMed
    Score: 0.002
  89. An historical perspective of multi-modality treatment for resectable non-small cell lung cancer. Lung Cancer. 1995 Jun; 12 Suppl 2:S17-32.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.